StageZero Life Sciences
Healthcare Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
70 E Beaver Creek Rd Unit 30, Richmond H...Phone Number
(855) 420-7140Revenue
<$5 MillionStock Symbol
SZLSIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
1
1
2
About StageZero Life Sciences
StageZero Life Sciences specializes in advanced cancer diagnostics and prevention programs aimed at improving cancer outcomes through early detection and intervention. Their flagship products, the Aristotle Test and AVRT, utilize innovative technology to identify cancer at earlier stages and assess risk factors for prevention. The company primarily serves self-funded health care plans and organizations, helping them reduce healthcare costs significantly by addressing cancer proactively. With a commitment to excellence, their laboratory is certified and accredited for high complexity testing, ensuring high-quality patient care.Explore more
StageZero Life Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is StageZero Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if StageZero Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on StageZero Life Sciences recently announced quarterly report
Click to see if StageZero Life Sciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at StageZero Life Sciences
Product Launch: Get notified when StageZero Life Sciences launches new products
StageZero Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if StageZero Life Sciences is spiking on competitors!
Funding: Get notified immidiatlly once StageZero Life Sciences has new funding data
Recommended Actions
Find VP level buyers at StageZero Life Sciences
Find 2 more new buyers
Compare Similar Companies to StageZero Life Sciences
Compare insights from companies similar to StageZero Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
StageZero Life Sciences is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
StageZero Life Sciences is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about StageZero Life Sciences.
StageZero Life Sciences Tech Stack
A closer look at the technologies used by StageZero Life Sciences
StageZero Life Sciences News & Media
StageZero Life Sciences Ltd. (SZLSF) Q4 2022 Earnings Call Transcript
StageZero Life Sciences Ltd. (OTCQB:SZLSF) Q4 2022 Results Conference Call April 3, 2023 7:00 AM ETCompany ParticipantsRebecca Greco - Head, Investor RelationsJames Howard-Tripp - Chairman...StageZero Life Sciences Ltd. Secures CAD $25 Million Capital Commitment from GEM ...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, ON / ACCESSWIRE / November 21, 2022 / StageZero Life Sciences Ltd. ("StageZero" or the "Company") (TSX:SZLS) today announced that it has entered into a capital commitment agreement (the "Agreement") with GEM Global Yield LLC SCS ("GGY") for a CAD $25 million Capital Commitment ("CC"). Draw downs are at the Company's discretion and subject to theStageZero Life Sciences Ltd. (SZLSF) Q3 2022 Earnings Call Transcript
StageZero Life Sciences Ltd. (OTCQB:SZLSF) Q3 2022 Earnings Conference Call November 15, 2022 08:30 A.M.StageZero Life Sciences Ltd. (SZLSF) CEO James Howard-Tripp on Q2 2022 Results - Earnings Call Transcript
StageZero Life Sciences Ltd. (OTCQB:SZLSF) Q2 2022 Earnings Conference Call August 16, 2022 08:30 AM ET Company Participants Rebecca Greco - Head, Investor Relations James Howard-Tripp -...
Read more news
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding StageZero Life Sciences
Sign Up For FreeTo access detailed company insights
StageZero Life Sciences specializes in advanced cancer diagnostics and prevention programs aimed at improving cancer outcomes through early detection and intervention. Their flagship products, the Aristotle Test and AVRT, utilize innovative technology to identify cancer at earlier stages and assess risk factors for prevention. The company primarily... Read More
